SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001172661-14-000477
Filing Date
2014-02-13
Accepted
2014-02-13 17:26:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G HOLDINGS REPORT drtx123113.htm SC 13G 93798
  Complete submission text file 0001172661-14-000477.txt   95295
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13G

Mailing Address 200 SOUTH WACKER DRIVE SUITE 2550 CHICAGO IL 60606
Business Address 200 SOUTH WACKER DRIVE SUITE 2550 CHICAGO IL 60606 312-219-7000
Durata Therapeutics, Inc. (Subject) CIK: 0001544116 (see all company filings)

IRS No.: 871247903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-86923 | Film No.: 14608036
SIC: 2834 Pharmaceutical Preparations